Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Daniel Williamson

Newcastle AuthorsTitleYearFull text
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Marina Danilenko
Dr Rebecca Hill
Dr Stephen Crosier
et al.		Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study2025
Dr Marion Mateos
Dr Daniel Williamson
Dr Marina Danilenko
Dr Jack Goddard
Dr Stephen Crosier
et al.		MDB-64. Novel transcripts associate with survival in childhood medulloblastoma.2024
Dr Florence Burté
Magretta Adiamah
Dr Fatma Scerif
Dr Debbie Hicks
Dr Ed Schwalbe
et al.		Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups2024
James Hacking
Dr Dean Thompson
Dr Ed Schwalbe
Professor Steven Clifford
Dr Daniel Williamson
Deriving a continuum score for group 3 and 4 medulloblastoma tumor samples analyzed via RNA-sequencing or DNA methylation microarray2023
Dr Jack Goddard
Jemma Castle
Emily Southworth
Anya Fletcher
Dr Stephen Crosier
et al.		Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification2023
Dr Daniel Williamson
The proteomic landscape of soft tissue sarcomas2023
Dr Daniel Williamson
Dr Ed Schwalbe
Professor Simon Bailey
Professor Steven Clifford
Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development2023
Dr Daniel Williamson
Professor Steven Clifford
Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma2022
Dr Stacey Richardson
Dr Rebecca Hill
Dr Christopher Kui
Dr Janet Lindsey
Dr Yura Grabovska
et al.		Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse2022
Dr Ricky Tirtakusuma
Dr Katarzyna Szoltysek
Professor Vasily Grinev
Dr Sirintra Nakjang
Dr Daniel Williamson
et al.		Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia2022
Dr Yura Grabovska
Dr Daniel Williamson
Erratum: Molecular subgrouping of atypical teratoid/rhabdoid tumors - a reinvestigation and current consensus (Neuro-Oncology DOI: 10.1093/neuonc/noz235)2022
Dr Jack Goddard
Dr Jemma Castle
Emily Southworth
Anya Fletcher
Dr Stephen Crosier
et al.		MEDB-71. Molecular characterisation of Group 4 medulloblastoma improves risk-stratification and its biological understanding2022
Dr Daniel Williamson
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Janet Lindsey
Dr Stephen Crosier
et al.		Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development2022
Dr Marina Danilenko
Dr Claire Keeling
Dr Stephen Crosier
Dr Martina Finetti
Dr Daniel Williamson
et al.		Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development2022
Dr Stephen Crosier
Dr Debbie Hicks
Dr Ed Schwalbe
Dr Daniel Williamson
Amanda Smith
et al.		Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics2021
123456